Cognition Therapeutics, Inc. (CGTX)
Track the next or latest earnings date for Cognition Therapeutics, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
public.com · 2 weeks ago
Looking to buy Cognition Therapeutics Stock? Get the latest CGTX quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.
CGTX: Cognition Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideasstocktwits.com · 2 weeks ago
Get real-time Cognition Therapeutics Inc (CGTX) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.
Tickerontickeron.com · 2 weeks ago
The Tickeron PE Growth Rating for ... average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents. The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), …
Cognition FDA backs Phase 3 plan for CT1812 | CGTX Stock Newswww.stocktitan.net · 2 weeks ago
FDA agreed DLB psychosis could support approval and aligned with Cognition on pivotal trial design. Phase 3 is expected to begin in mid-2027.
CGTX Q4 2025 Earnings Report on 3/26/2026www.marketbeat.com · March 26, 2026
Cognition Therapeutics announced their Q4 2025 earnings on 3/26/2026. View CGTX's earnings results, press release, and conference call transcript at MarketBeat.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: -$0.06
Revenue estimate: N/A
Market cap: $94.45M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Mar 19, 2026 | 2025-12-31 | Time not specified | -$0.06 | N/A |